Table 1

Patient baseline clinical and demographic details: data are expressed and number (%) or mean±SD

Baseline clinical characteristicsn=26
Age (years)25±8
Male14 (54%)
F508 del homozygous15 (58%)
BMI (kg/m2)21±3
CFRD8 (31%)
Pancreatic insufficiency25 (96%)
Inhaled steroids21 (81%)
Long-term azithromycin25 (96%)
Long-term nebulised antibiotics25 (96%)
Triazole therapy >3 months prior to enrolment2 (8%)
Chronic Pseudomonas26 (100%)
Chronic Burkholderia spp1 (4%)
Chronic MSSA9 (35%)
Chronic MRSA0 (0%)
NTM1 (4%)
FEV1% predicted42±15
FVC % predicted59±17
  • BMI, body mass index; CFRD, cystic fibrosis-related diabetes; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-sensitive Staphylococcus aureus; NTM, non-tuberculous mycobacteria.